Literature DB >> 9805508

Systemic treatment for prostate cancer.

A J Dowling1, I F Tannock.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9805508     DOI: 10.1016/s0305-7372(98)90062-7

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  11 in total

Review 1.  Prostate cancer: 11. Alternative approaches and the future of treatment.

Authors:  J Trachtenberg; J Crook; I F Tannock
Journal:  CMAJ       Date:  1999-02-23       Impact factor: 8.262

Review 2.  A history of prostate cancer treatment.

Authors:  Samuel R Denmeade; John T Isaacs
Journal:  Nat Rev Cancer       Date:  2002-05       Impact factor: 60.716

Review 3.  Optimisation of treatment by applying programmable rate-controlled drug delivery technology.

Authors:  Yie W Chien; Senshang Lin
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

4.  Molecular Basis of Steroid Action in the Prostate.

Authors:  Yuan-Shan Zhu
Journal:  Cellscience       Date:  2005-04-28

5.  Configurations of a two-tiered amplified gene expression system in adenoviral vectors designed to improve the specificity of in vivo prostate cancer imaging.

Authors:  M Sato; M L Figueiredo; J B Burton; M Johnson; M Chen; R Powell; S S Gambhir; M Carey; L Wu
Journal:  Gene Ther       Date:  2008-02-28       Impact factor: 5.250

6.  Functionality of androgen receptor-based gene expression imaging in hormone refractory prostate cancer.

Authors:  Makoto Sato; Mai Johnson; Liqun Zhang; Sanjiv S Gambhir; Michael Carey; Lily Wu
Journal:  Clin Cancer Res       Date:  2005-05-15       Impact factor: 12.531

7.  Cabazitaxel versus docetaxel for treatment of metastatic castrate refractory prostate cancer.

Authors:  Nicholas D James; Ayesha Ali; Ann Pope; Amisha Desai; Daniel Ford; Robert Stevenson; Anjali Zarkar; Sarah Pirrie
Journal:  BJUI Compass       Date:  2022-06-18

8.  17alpha-estradiol inhibits LAPC-4 prostatic tumor cell proliferation in cell cultures and tumor growth in xenograft animals.

Authors:  Yaming Qiao; Zhi-Kai Zhang; Li-Qun Cai; Chen Tan; Julianne L Imperato-McGinley; Yuan-Shan Zhu
Journal:  Prostate       Date:  2007-12-01       Impact factor: 4.104

9.  NSC606985, a novel camptothecin analog, induces apoptosis and growth arrest in prostate tumor cells.

Authors:  Chen Tan; Li-Qun Cai; Wendy Wu; Yaming Qiao; Julianne Imperato-McGinley; Guo-Qiang Chen; Yuan-Shan Zhu
Journal:  Cancer Chemother Pharmacol       Date:  2008-03-29       Impact factor: 3.333

10.  Differential effects of estrogen receptor ligands on regulation of dihydrotestosterone-induced cell proliferation in endothelial and prostate cancer cells.

Authors:  Chunyan Weng; Jingjing Cai; Juan Wen; Hong Yuan; Kan Yang; Julianne Imperato-McGinley; Yuan-Shan Zhu
Journal:  Int J Oncol       Date:  2012-11-06       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.